within leslie chong experience it is truly remarkable Within her experience of developing numerous world class oncology medicines it is truly remarkable to have all our sites’ Ethics Committee review applications completed and submitted within 7 weeks of finalising the study protocol. Reaching this major milestone so efficiently demonstrates the calibre of Imugene’s clinical development team and strategically places us well for a successful re-entry of Her-Vaxx into the clinic in 2016”.
IMU completes submission to Hospital Ethics Committees for HER-Vaxx, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.34M | |||
| Open | High | Low | Value | Volume |
| 40.5¢ | 42.5¢ | 39.0¢ | $106.6K | 262.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 559 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.5¢ | 16517 | 2 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |